Llilianne Ganges Selected Research

Classical Swine Fever (Swine Fever)

1/2022	Removal of the Erns RNase Activity and of the 3' Untranslated Region Polyuridine Insertion in a Low-Virulence Classical Swine Fever Virus Triggers a Cytokine Storm and Lethal Disease.
10/2021	Development of a Dendrimeric Peptide-Based Approach for the Differentiation of Animals Vaccinated with FlagT4G against Classical Swine Fever from Infected Pigs.
1/2020	A neutralizing monoclonal antibody-based competitive ELISA for classical swine fever C-strain post-vaccination monitoring.
1/2020	A Polyuridine Insertion in the 3' Untranslated Region of Classical Swine Fever Virus Activates Immunity and Reduces Viral Virulence in Piglets.
7/2019	Investigation of chronic and persistent classical swine fever infections under field conditions and their impact on vaccine efficacy.
7/2015	Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigs.
2/2008	Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats.
9/2005	Origin and evolution of viruses causing classical swine fever in Cuba.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Llilianne Ganges Research Topics

Disease

16	Infections 05/2022 - 05/2006
8	Classical Swine Fever (Swine Fever) 01/2022 - 09/2005
3	Virus Diseases (Viral Diseases) 01/2020 - 02/2008
3	Disease Progression 08/2017 - 04/2011
2	Superinfection 07/2019 - 01/2016
2	Fever (Fevers) 02/2013 - 05/2005
2	Viremia 05/2006 - 05/2005
1	Cytokine Release Syndrome 01/2022
1	Persistent Infection 12/2021
1	Orthomyxoviridae Infections 10/2021
1	Human Influenza (Influenza) 10/2021
1	Foot-and-Mouth Disease 05/2021
1	Communicable Diseases (Infectious Diseases) 05/2021
1	Hyperthermia 05/2005

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 10/2021 - 05/2005
5	Glycoproteins (Glycoprotein)IBA 05/2022 - 09/2005
4	AntibodiesIBA 08/2011 - 05/2006
3	Neutralizing AntibodiesIBA 01/2022 - 05/2005
3	RNA (Ribonucleic Acid)IBA 08/2017 - 06/2014
3	DNA VaccinesIBA 02/2013 - 05/2006
2	Interferon-alpha (Interferon Alfa)IBA 05/2022 - 01/2020
2	Ribonucleases (Ribonuclease)IBA 01/2022 - 12/2021
2	3' Untranslated Regions (3' UTR)IBA 01/2022 - 01/2020
2	Poly UIBA 01/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2013
2	Peptides (Polypeptides)IBA 10/2021 - 05/2021
2	CytokinesIBA 01/2020 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 08/2017
2	DNA (Deoxyribonucleic Acid)IBA 08/2017 - 04/2011
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2012 - 05/2006
1	Broadly Neutralizing AntibodiesIBA 05/2022
1	Monoclonal AntibodiesIBA 01/2020
1	Interleukin-27 (Interleukin 27)IBA 01/2020
1	LigandsIBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	Interleukin-15 (Interleukin 15)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Attenuated VaccinesIBA 07/2019
1	Interleukin-10 (Interleukin 10)IBA 08/2017
1	Interferon Type IIBA 08/2017
1	NucleoproteinsIBA 02/2013
1	Dihydrotachysterol (AT 10)IBA 04/2011
1	DisulfidesIBA 02/2008
1	1-dodecylpyridoxal (PLD)IBA 02/2008
1	12E7 AntigenIBA 02/2008
1	Protein Sorting Signals (Signal Peptide)IBA 05/2006
1	EpitopesIBA 05/2006
1	NucleotidesIBA 09/2005
1	Viral AntibodiesIBA 05/2005

Therapy/Procedure

1	Intramuscular Injections 02/2008